72 related articles for article (PubMed ID: 349597)
21. Short-term double-blind trial of pipothiazine palmitate and haloperidol in the acute phase of schizophrenia.
Bechelli LP; Navas-Filho F
Encephale; 1986; 12(3):121-5. PubMed ID: 2876879
[TBL] [Abstract][Full Text] [Related]
22. Minimal effective dose and relapse--double-blind trial: haloperidol decanoate vs. placebo.
Eklund K; Forsman A
Clin Neuropharmacol; 1991; 14 Suppl 2():S7-12; discussion S12-5. PubMed ID: 1684310
[TBL] [Abstract][Full Text] [Related]
23. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements after neuroleptic dose decrease.
Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG
Psychopharmacol Bull; 1992; 28(1):101-7. PubMed ID: 1609034
[TBL] [Abstract][Full Text] [Related]
24. Higher than usual dosage of haloperidol: a pilot study in 'back ward' schizophrenics.
Tanghe A; Declercq H
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):50-3. PubMed ID: 798191
[TBL] [Abstract][Full Text] [Related]
25. Long-term efficacy and safety of iloperidone: results from 3 clinical trials for the treatment of schizophrenia.
Kane JM; Lauriello J; Laska E; Di Marino M; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S29-35. PubMed ID: 18334910
[TBL] [Abstract][Full Text] [Related]
26. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
Luckey WT; Schiele BC
Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
[No Abstract] [Full Text] [Related]
27. Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
Garver DL; Hirschowitz J; Glicksteen GA; Kanter DR; Mavroidis ML
J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272
[TBL] [Abstract][Full Text] [Related]
28. A randomized clinical trial of haloperidol decanoate and fluphenazine decanoate in the outpatient treatment of schizophrenia.
Chouinard G; Annable L; Campbell W
J Clin Psychopharmacol; 1989 Aug; 9(4):247-53. PubMed ID: 2570086
[TBL] [Abstract][Full Text] [Related]
29. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
López Ibor JJ; Ayuso JL; Gutiérrez M; Guimon J; Herraiz ML; Chinchilla A; Ayuso JL; González Pinto A; Eguiluz I; Fernández A
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996; 24(4):165-72. PubMed ID: 8984849
[TBL] [Abstract][Full Text] [Related]
30. A comparison of parenteral loxapine and haloperidol in hostile and aggressive acutely schizophrenic patients.
Tuason VB
J Clin Psychiatry; 1986 Mar; 47(3):126-9. PubMed ID: 3512535
[TBL] [Abstract][Full Text] [Related]
31. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.
Pacquay M; Brasseur F
Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190
[TBL] [Abstract][Full Text] [Related]
32. Plasma haloperidol levels and clinical response in acute schizophrenia.
Extein I; Augusthy KA; Gold MS; Pottash AL; Martin D; Potter WZ
Psychopharmacol Bull; 1982 Oct; 18(4):156-8. PubMed ID: 7156281
[No Abstract] [Full Text] [Related]
33. Speed and rate of remission in acute schizophrenia: a comparison of intramuscularly administered fluphenazine HC1 with thiothixene and haloperidol.
Levenson AJ; Burnett GB; Nottingham JD; Sermas CE; Thornby JI
Curr Ther Res Clin Exp; 1976 Nov; 20(5):695-700. PubMed ID: 825356
[No Abstract] [Full Text] [Related]
34. Variable dose studies provide misleading therapeutic windows.
Van Putten T; Marder SR
J Clin Psychopharmacol; 1986 Feb; 6(1):55-6. PubMed ID: 3950069
[No Abstract] [Full Text] [Related]
35. Haloperidol levels and clinical response.
Cohen BM; Baldessarini RJ
Am J Psychiatry; 1981 Nov; 138(11):1513-4. PubMed ID: 7294231
[No Abstract] [Full Text] [Related]
36. [Studies on the treatment of chronic simple schizophrenia with haloperidol].
Kaczyński M; Bernaśkiewicz E; Wypych M; Wojnicka H
Neurol Neurochir Psychiatr Pol; 1965; 15(2):281-7. PubMed ID: 5320012
[No Abstract] [Full Text] [Related]
37. Haloperidol metabolism and antipsychotic effect in schizophrenia.
Altamura AC; Mauri MC; Cavallaro R; Gorni A
Lancet; 1987 Apr; 1(8536):814-5. PubMed ID: 2882227
[No Abstract] [Full Text] [Related]
38. Haloperidol in the treatment of stutterers.
Quinn PT; Peachey EC
Br J Psychiatry; 1973 Aug; 123(573):247-8. PubMed ID: 4582238
[No Abstract] [Full Text] [Related]
39. Measurement of haloperidol in human plasma using reversed-phase high-performance liquid chromatography.
Jatlow PI; Miller R; Swigar M
J Chromatogr; 1982 Jan; 227(1):233-8. PubMed ID: 7056816
[No Abstract] [Full Text] [Related]
40. Theoretical and practical importance of plasma levels of haloperidol. Correlations with clinical and computerized EEG data.
De Buck RP; Zelaschi N; Gilles C; Durdu J; Brauman H
Prog Neuropsychopharmacol; 1981; 5(5-6):499-502. PubMed ID: 7339639
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
